|
|
Systems Biology:Key to Unlocking the Value within the Omics RevolutionPublished by: Drug and Market Development Publishing Published: Jan. 1, 2004 - 185 Pages Table of Contents1 Executive Summary Technology Background Technologies for Systems Biology Market Activity and Prospects Future Trends 2 Introduction Scope and Objectives of the Report 3 Technology Background Definitions of Systems Biology Computational Systems Biology Data-Driven or Integrational Systems Biology Evolution of Systems Biology Origins of Systems Biology Genomics and the Rebirth of Discovery Research in Biology 4 Technologies for Systems Biology Data-Driven Systems Biology Transcriptomics Genetic Variation Proteomics Metabolomics Informatics for Data-Driven Systems Biology Progress in Data--Driven Systems Biology Basic Systems Biology Computational Systems Biology Methodology Progress in Computational Systems Biology The Systems Biology Research Community 5 Commercial Applicability Pharmaceutical Applications Diagnostic Applications Other Applications 6 Market Activity and Prospects Systems Biology Company Business Models and Deals 7 Future Trends 8 Company Profiles 3rd Millennium, Inc. Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property Aclara Biosciences Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property Beyond Genomics Company Management Company Overview Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property BioSeek, Inc Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property Cellzome AG Company Management Company Overview Company Financials Technology, Research, and Developmen. Products and Product Pipeline Strategic Alliances Intellectual Property Entelos, Inc. Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property Genedata AG Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property GeneGo, Inc. Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property Gene Network Sciences Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property Gene Networks, Inc. Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property Genomatica, Inc. Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property IBM Corporation Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic AlliancesIngenuity Systems Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property The Institute for Systems Biology Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Paradigm Genetics Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property Predix Pharmaceuticals, Inc. Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property Protein Pathways, Inc. Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property Target Discovery Company Management Company Overview Company Financials Technology, Research, and Development Products and Product Pipeline Strategic Alliances Intellectual Property 9 Interviews with Industry Experts Michael French, Sr. VP, Business Development and Alliances, Entelos Stephen Naylor, Ph.D., Consultant, Boston, Massachusetts Colin Hill, Gene Network Sciences, CEO, President, and Chairman Robert N. McBurney, CSO and Sr. VP. R&D, Beyond Genomics Frank Mara, Sr. VP Marketing, Ingenuity Systems Yury Rozenman, Senior Marketing Manger, Pharmaceutical Sector, IBM AbstractThis Report describes the current state and future prospects of the rapidly developing systems biology field. D&MD's Systems Biology Report clearly defines what systems biology is and does. An historical overview of the field is provided and the technical and commercial background is detailed. The nature of systems biology is examined in its several manifestations; commercial applications in pharmaceutical, diagnostic, and other business segments; and market dynamics. A series of detailed profiles of companies active in the field is followed by in-depth interviews with six systems biology experts.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||